Daito Pharmaceutical Co.,Ltd.

TSE:4577 Stok Raporu

Piyasa değeri: JP¥34.0b

Daito PharmaceuticalLtd Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

Daito PharmaceuticalLtd's earnings have been declining at an average annual rate of -5%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 0.2% per year. Daito PharmaceuticalLtd's return on equity is 5.7%, and it has net margins of 6.8%.

Anahtar bilgiler

-5.0%

Kazanç büyüme oranı

-7.9%

EPS büyüme oranı

Pharmaceuticals Sektör Büyümesi3.4%
Gelir büyüme oranı0.2%
Özkaynak getirisi5.7%
Net Marj6.8%
Son Kazanç Güncellemesi31 Aug 2024

Yakın geçmiş performans güncellemeleri

Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 19
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 19
Daito PharmaceuticalLtd's (TSE:4577) Weak Earnings May Only Reveal A Part Of The Whole Picture

Gelir ve Gider Dağılımı

Daito PharmaceuticalLtd nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

TSE:4577 Gelir, gider ve kazançlar (JPY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
31 Aug 2447,3953,2303,4382,349
31 May 2446,8953,2953,4312,349
29 Feb 2445,1933,2793,4121,865
30 Nov 2345,8443,3903,3881,865
31 Aug 2345,2383,3373,1961,865
31 May 2345,1013,6003,0781,865
28 Feb 2344,4513,3503,3721,749
30 Nov 2244,3683,6533,3991,749
31 Aug 2243,7593,7893,3491,749
31 May 2243,4644,6682,9901,749
28 Feb 2244,4624,5252,6582,032
30 Nov 2145,1424,6002,5612,032
31 Aug 2146,7574,7502,4362,032
31 May 2148,7144,2462,7122,032
28 Feb 2148,4544,4023,1751,400
30 Nov 2047,7734,3653,0131,400
31 Aug 2047,0364,3452,9261,400
31 May 2044,9913,9442,6091,400
29 Feb 2045,1054,2042,3661,608
30 Nov 1944,2423,8422,2511,608
31 Aug 1943,0533,6542,2831,608
31 May 1941,1343,5132,3941,608
28 Feb 1940,6403,2912,3001,522
30 Nov 1839,5663,1272,4051,522
31 Aug 1839,9333,1472,2461,522
31 May 1839,8753,0412,3011,522
28 Feb 1839,7012,9132,5541,266
30 Nov 1739,2192,8202,4141,266
31 Aug 1738,5542,6582,5421,266
31 May 1737,9842,6562,3941,266
28 Feb 1737,2832,6982,5231,174
30 Nov 1637,2702,7222,4381,174
31 Aug 1636,7472,5592,2821,174
31 May 1636,3702,5662,3481,174
29 Feb 1636,4162,6392,1071,182
30 Nov 1535,6912,4032,3581,182
31 Aug 1535,3702,4682,3531,182
31 May 1534,0582,2462,2431,182
28 Feb 1533,7652,0802,531890
30 Nov 1432,5282,0102,168890
31 Aug 1431,5601,8642,033890
31 May 1431,1961,8112,029890
28 Feb 1429,8761,9101,7511,113
30 Nov 1329,6801,7871,8711,113

Kaliteli Kazançlar: 4577 has high quality earnings.

Büyüyen Kar Marjı: 4577's current net profit margins (6.8%) are lower than last year (7.4%).

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 4577's earnings have declined by 5% per year over the past 5 years.

Büyüme Hızlandırma: 4577's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 4577 had negative earnings growth (-3.2%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (38.7%).

Özkaynak Getirisi

Yüksek ROE: 4577's Return on Equity (5.7%) is considered low.

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin

7D

1Y

7D

1Y

7D

1Y